Evidence map›Paper›PMID 28644889›Full record

ArticlePLoS neglected tropical diseases2017

Evaluation of different serological assays for early diagnosis of leptospirosis in Martinique (French West Indies).

Christophe Courdurie, Yohann Le Govic, Pascale Bourhy, Dorothee Alexer, Karine Pailla, Rafaelle Theodose, Raymond Cesaire, Jacques Rosine, Patrick Hochedez, Claude Olive

Abstract readComparative StudyEvaluation Study
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. A Retrospective Cohort Study of Leptospirosis in Crete, Greece.Tropical medicine and infectious disease · 2025
    Article
  4. Advancing serologic diagnosis: assessing the efficacy of rErpY-like protein in human leptospirosis detection.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  5. Observational
  6. Leptospirosis infections among hospital patients, Sarawak, Malaysia.Tropical diseases, travel medicine and vaccines · 2021
    Article
  7. Evaluation of a genus-specific rGroELScientific reports · 2021
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Christophe CourdurieDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.ORCID http://orcid.org/0000-0003-1264-0366
Yohann Le GovicDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.
Pascale BourhyDepartment of Spirochetes Biology, Pasteur Institute, National Reference Center and WHO Collaborating Center for Leptospirosis, Paris, France.
Dorothee AlexerDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.
Karine PaillaDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.
Rafaelle TheodoseDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.
Raymond CesaireDepartment of Virology, University Hospital of Fort-de-France, Martinique, French West Indies.
Jacques RosineInterregional Epidemiology Unit, French Institute for Public Health Surveillance, Fort-de-France, Martinique, French West Indies.
Patrick HochedezDepartment of Infectious Diseases, University Hospital of Fort-de-France, Martinique, French West Indies.
Claude OliveDepartment of Bacteriology and Hygiene, University Hospital of Fort-de-France, Martinique, French West Indies.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeptospirosis is a potentially life-threatening but curable zoonosis whose prognosis depends on accurate and timely diagnosis. Because of its non-specific clinical presentation, laboratory testing is essential to confirm the diagnosis. Here, we aimed to assess the performance of two enzyme-linked immunosorbent assays (ELISAs) (ELISA Serion and ELISA-Hb Pasteur) and one immunodot (GenBio) using quantitative PCR (qPCR) as gold standard, instead of the traditional microscopic agglutination test, for the diagnosis of acute leptospirosis in an endemic area. METHODOLOGY/PRINCIPAL

findingsBetween January 2011 and December 2012, a total of 122 patients were diagnosed with leptospirosis, as confirmed by qPCR at the University Hospital of Martinique. Among them, 103 had at least one serum sample available for analysis. Performance of each serological assay was evaluated according to days' post onset of symptoms (DPO) and local species diversity (which included L. santarosai, L. interrogans, L. kirschneri, L. borgpetersenii, L. noguchii, and L. kmetyi). Several thresholds were tested to optimize accuracy. When considering the manufacturer's threshold, the sensitivity of ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot was 75%, 67% and 64%, while specificity was 92%, 98% and 100%, respectively. Moreover, the threshold optimization allowed a significant improvement in specificity for the ELISA Serion from 92% to 99% (p<0.05). During the first 5 DPO, sensitivities were 35%, 30% and 42% for ELISA Serion, ELISA-Hb Pasteur and GenBio immunodot, respectively. However, between 6─10 DPO, these sensitivities dramatically increased to reach 86%, 76% and 67%, respectively. Performances of the three assays were not affected by the species studied. CONCLUSIONS/SIGNIFICANCE: All these serological assays showed the potential for diagnosing leptospirosis after (but not before) 6 days' post onset of symptoms. In a high prevalence setting, where highest specificities are needed, threshold optimizing should be performed for this purpose.

Indexed as

Early DiagnosisEnzyme-Linked Immunosorbent AssayHumansImmunoblottingLeptospirosisMartiniqueSensitivity and SpecificitySerologic TestsTime Factors

Identifiers

PMID28644889
PMCPMC5500375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.